Merck & Co., Inc. is 183.8x more valuable than Nuvation Bio Inc. by market capitalization ($293.16 B vs $1.59 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NUVB | MRK |
|---|---|---|
| Market cap | $1.59 B | $293.16 B |
| US-listed rank | #2273 | #44 |
| Revenue (latest FY) | $62.90M | $65.01B |
| Net income (latest FY) | -$204.63M | $18.25B |
| Net margin | -325.3% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 379 | 996 |
Merck & Co., Inc. is 183.8x more valuable than Nuvation Bio Inc. by market capitalization ($293.16 B vs $1.59 B).
In their latest fiscal years, Nuvation Bio Inc. reported $62.90M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Nuvation Bio Inc. and Merck & Co., Inc., or browse the full rankings.